Linde plc (NYSE: LIN) beat third-quarter estimates with adjusted EPS of $4.59 and revenue of $9.40 billion, but the stock slipped as investors focused on flat underlying margins, a $425 million restructuring charge, and the ongoing Lincare drag. Management kept full-year 2026 EPS guidance at $17.82 to $17.92 and signaled no economic improvement, while analysts remained constructive on the company’s electronics growth, project backlog, and capital returns.
Linde plc (LIN) slips 1.17% to $502.21 after its October 29, 2026 earnings report beat estimates on adjusted EPS and revenue. The $4.59 EPS result and $9.40B in sales were solid, but flat underlying margins, a $425M restructuring charge, and the ongoing Lincare drag kept investors measured.
Key Takeaways
LIN earnings beat both benchmarks: adjusted EPS reached $4.59 versus the $4.52 estimate, while revenue came in at $9.40B versus $9.16B.
Electronics led end-market growth at 15%, followed by Chemicals & Energy at 12% and Manufacturing at 7%.
Fourth-quarter EPS guidance is $4.40 to $4.50. Full-year 2026 EPS guidance is $17.82 to $17.92, with no economic improvement assumed.
Linde recorded a $425M restructuring charge, with roughly half tied to severance and much of the remaining amount linked to portfolio and asset actions at Lincare.
CEO Sanjiv Lamba said the company is taking action on costs, pricing, productivity, and Lincare while continuing to invest in an $8B sale-of-gas project backlog.
Sell-side reaction remained constructive. Mizuho raised its target to $583 from $575 and kept Outperform, while Bernstein reiterated Buy at $562. Coverage consensus remains Buy, with 26 Buy ratings and 3 Holds.
Financial Performance: Revenue, Margins, and EPS
Linde posted Q3 sales of $9.40B, up 9% from the prior year. Revenue also increased from $9.29B in Q2, $8.78B in Q1, $8.76B in Q4 2025, and $8.62B in Q3 2025. That sequence shows steady top-line expansion, even as the earnings mix remains uneven.
Underlying sales growth was 5%. Volume contributed 2%, prices added 3%, and currency contributed 1%. Acquisitions and engineering each added 1% to reported sales growth. The mix matters because Linde's volume gains remain concentrated in selected markets, while pricing gains are broader.
Operating profit rose 8% to $2.8B. However, the 29.4% operating margin fell 30 basis points from the prior year. Excluding cost pass-through, the margin was flat. Higher margins in the combined gas segments were offset by declines in Engineering and Global Other.
Adjusted EPS reached $4.59, up 9% year over year and 8% excluding currency. The earnings-surprise history shows adjusted EPS of $4.50 in Q2, $4.33 in Q1, and $4.21 in Q3 2025. The company therefore extended a consistent pattern of beating estimates, although the latest beat was modest at $0.07 per share.
The end-market breakdown gives the clearest view of current momentum. Electronics grew 15%, supported by organic demand in APAC and the U.S. Linde has about $2B of electronics projects under construction in the U.S., Korea, and China. Chemicals & Energy grew 12%, helped by stronger U.S. and Chinese volumes. Food & Beverage rose 3%, while Healthcare increased 2%, or mid-single digits excluding Lincare.
Manufacturing grew 7%, with gains in the U.S., China, and India. Metals and Mining rose 3%, led by the Americas but partly offset by contractions in EMEA and APAC. U.S. packaged gas growth remained in the low teens, supported by construction and data center activity. These figures point to a strong industrial and electronics core, with weaker results in selected non-gas operations.
Cash generation also held up. Operating cash flow rose 8% to $3.2B. Linde deployed more than $9B of capital year to date, with roughly half invested in the business and the remainder returned to shareholders. That combination supports the company's long-standing capital allocation model, even as restructuring absorbs attention.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
LIN shares traded at $502.21 during the October 29 regular session, down 1.17%. Volume was 1,796,279 shares against an average of 2,080,743. The muted move shows that a beat alone was not enough to reset sentiment around a premium industrial stock.
Mizuho delivered the clearest bullish response. The firm raised its price target to $583 from $575 and maintained Outperform. Mizuho highlighted the $4.59 EPS result, 15% Electronics growth, 12% Chemicals & Energy growth, and a project backlog it valued at roughly $11B across sale-of-gas and sale-of-plant activity.
Bernstein kept its Buy rating and $562 target unchanged. Its view was more cautious on the near-term path back to 8% to 12% adjusted EPS growth, while it identified a Lincare solution and additional project wins as potential catalysts. Jefferies had already raised its target to $591 from $560 on October 23, before the earnings report. UBS maintained Buy while lowering its target.
The split between positive ratings and restrained trading is important. Analysts continue to value Linde's gas network, project backlog, and electronics exposure. At the same time, the stock still needs margin improvement and a cleaner Lincare outcome to produce a stronger market response.
Management Commentary: Strategy, Pricing, and Guidance
CEO Sanjiv Lamba framed the quarter as a response to the weaker performance that preceded it. The restructuring charge, the Lincare reporting change, and broader price and productivity actions all point to a sharper focus on return quality rather than growth at any cost.
"Three months ago, we delivered financial results that were not up to the expectation of our owners. That message was received loud and clear by the Linde organization. And so we have and will continue to take actions that increase shareholder value." - Sanjiv Lamba, CEO, Earnings Call
Lamba's broader message was that the core gas business remains healthy, but its performance is not uniform. Electronics, chemicals, U.S. packaged gas, and the project backlog provide growth support. Lincare remains a drag, and the company moved the business into Global Other under CFO Matt White's oversight while evaluating strategic alternatives.
"For the fourth quarter, we're guiding an EPS range of $4.40 to $4.50, or 5% to 7% growth. While no prior year currency impact is assumed, we do expect a 1% headwind sequentially." - Matthew White, CFO, Earnings Call
CFO Matthew White also said Linde is not embedding meaningful Q4 profit improvement from Lincare. That caution keeps the guidance credible, but it also places more weight on pricing, productivity, and the core gas businesses. The full-year guide of $17.82 to $17.92 incorporates the year-to-date result and Q4 range.
The LIN earnings call put two pressure points under the microscope: project backlog conversion and the sharp increase in reported costs. Those exchanges added useful detail behind the headline beat.
"On the backlog, do you still expect to end the year on a sale of gas basis around the $8 billion level? And on sale of plant, how should that progress over the next few quarters?" - David Begleiter, Deutsche Bank
"The sale of backlog sits close to $8 billion today. My expectation remains we will continue to start up for the rest of this quarter, a number of projects that might lead up to around $1 billion." - Sanjiv Lamba, CEO, Earnings Call
Lamba defended the $8B sale-of-gas target while acknowledging customer timing can affect the year-end figure. He also put the sale-of-plant backlog at just under $3B and said it should grow over the course of next year. Together, those figures support Mizuho's broader roughly $11B backlog view.
"If you look at your COGS line in Q3, year-over-year, you're up 13% and your acquisitions and volume are up 3%. So if you just subtract that, kind of a cheap metric would say that your per unit COGS is up about 10% per unit." - Patrick Fischer, Goldman Sachs
"You got to start with FX, right? So that's up 1%. Cost pass-through is another 1%. In addition, as you saw, the energy market did quite strong, and a lot of that's on the back of HyCO, our hydrogen business, which tends to have a higher variable cost." - Matthew White, CFO, Earnings Call
White added that pricing recovery looked more prominent because Lincare moved out of the Americas segment. He expects the effect to come down in Q4. That answer matters because the 29.4% margin did not expand despite the revenue beat. Linde is recovering energy and distribution costs, but the recovery is not yet producing clean operating leverage.
Bottom Line
Linde plc earnings analysis points to a durable core business with strong electronics and industrial demand, consistent cash generation, and a large project backlog. However, the 1.17% share-price decline, flat underlying margin, and Lincare restructuring show why investors still want proof that operational fixes can convert into stronger earnings quality.
Yes. Linde reported adjusted EPS of $4.59 versus the $4.52 estimate and revenue of $9.40 billion versus $9.16 billion expected. The company also said sales rose 9% year over year.
+Why did Linde stock fall after the earnings beat?
Shares fell 1.17% because investors looked past the beat and focused on flat underlying margins, a $425 million restructuring charge, and the ongoing Lincare drag. The market reaction showed that a modest earnings beat was not enough to change sentiment on the premium-valued stock.
+What was Linde's Q4 and full-year 2026 guidance?
Linde guided fourth-quarter adjusted EPS to $4.40 to $4.50. For full-year 2026, it guided adjusted EPS to $17.82 to $17.92 and said it was not assuming any economic improvement.
+Which end markets drove Linde's growth in Q3?
Electronics was the strongest end market, growing 15%, followed by Chemicals & Energy at 12% and Manufacturing at 7%. Linde also said U.S. packaged gas growth remained in the low teens, supported by construction and data center activity.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on LIN?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
